{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:11:17Z","timestamp":1777529477939,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bbr.2012.05.015","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T04:42:33Z","timestamp":1337661753000},"page":"298-304","source":"Crossref","is-referenced-by-count":15,"title":["The selective neuropeptide Y Y5 agonist [cPP1\u20137,NPY19\u201323,Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat"],"prefix":"10.1016","volume":"233","author":[{"given":"J.C.","family":"Morales-Medina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dominguez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Beck-Sickinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quirion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2012.05.015_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10880-011-9248-1","article-title":"Human and economic burden of GAD, subthreshold GAD, and worry in a Primary care sample","volume":"18","author":"Kertz","year":"2011","journal-title":"Journal of Clinical Psychology in Medical Settings"},{"key":"10.1016\/j.bbr.2012.05.015_bib0010","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpsychires.2011.03.006","article-title":"Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness","volume":"45","author":"McLean","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.genhosppsych.2007.12.006","article-title":"Anxiety disorders and comorbid medical illness","volume":"30","author":"Roy-Byrne","year":"2008","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.bbr.2012.05.015_bib0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABA(A) receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.bbr.2012.05.015_bib0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0030","series-title":"Neurobiology of depression","article-title":"Role of neuropeptide Y in depression: current status","author":"Morales-Medina","year":"2011"},{"key":"10.1016\/j.bbr.2012.05.015_bib0035","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00001756-199906030-00022","article-title":"Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder","volume":"10","author":"Caberlotto","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.bbr.2012.05.015_bib0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-3806(01)00264-4","article-title":"Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats","volume":"131","author":"Jimenez-Vasquez","year":"2001","journal-title":"Brain Research Developmental Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pnpbp.2009.10.011","article-title":"Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew","volume":"34","author":"Zambello","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.bbr.2012.05.015_bib0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0055","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.peptides.2005.03.029","article-title":"Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test","volume":"26","author":"Redrobe","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2012.05.015_bib0060","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3956(03)00101-8","article-title":"Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism","volume":"38","author":"Heilig","year":"2004","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0070","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2006.04.026","article-title":"CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder","volume":"1095","author":"Hou","year":"2006","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euroneuro.2004.01.005","article-title":"Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment","volume":"14","author":"Olsson","year":"2004","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2009.02.009","article-title":"PreproNPY Pro7 protects against depression despite exposure to environmental risk factors","author":"Sjoholm","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.bbr.2012.05.015_bib0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature06858","article-title":"Genetic variation in human NPY expression affects stress response and emotion","volume":"452","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2012.05.015_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","article-title":"XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.bbr.2012.05.015_bib0095","series-title":"Transmitters and modulators in health and disease","first-page":"51","article-title":"Neuropeptide Y an its role in anxiety-related disorders","author":"Dumont","year":"2009"},{"key":"10.1016\/j.bbr.2012.05.015_bib0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<372::AID-CNE6>3.0.CO;2-2","article-title":"Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains","volume":"402","author":"Dumont","year":"1998","journal-title":"Journal of Comparative Neurology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000054676","article-title":"Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype","volume":"74","author":"Campbell","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuropharm.2010.09.016","article-title":"Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas","volume":"60","author":"Quarta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0115","doi-asserted-by":"crossref","first-page":"36043","DOI":"10.1074\/jbc.M000626200","article-title":"The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats","volume":"275","author":"Cabrele","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.bbr.2012.05.015_bib0120","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.bjp.0705389","article-title":"Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs","volume":"139","author":"Lecklin","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0125","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1152\/jn.00532.2001","article-title":"Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus","volume":"87","author":"Guo","year":"2002","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0028-3908(02)00234-4","article-title":"Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats","volume":"43","author":"Sajdyk","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20200","article-title":"Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation","volume":"77","author":"Sorensen","year":"2004","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0140","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1073\/pnas.0705615105","article-title":"Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy","volume":"105","author":"Mitra","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bbr.2012.05.015_bib0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"The olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.bbr.2012.05.015_bib0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","article-title":"Role of neuropeptide Y Y(1) and Y(2) receptors on behavioral despair in a rat model of depression with co-morbid anxiety","volume":"62","author":"Morales-Medina","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0155","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbr.2007.01.003","article-title":"Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety","volume":"178","author":"Wang","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0160","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1523\/JNEUROSCI.14-09-05373.1994","article-title":"Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus","volume":"14","author":"Stein-Behrens","year":"1994","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.05.015_bib0165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-004-2122-1","article-title":"Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study","volume":"179","author":"Hasegawa","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0170","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jnr.20620","article-title":"Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression","volume":"82","author":"Tanaka","year":"2005","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0175","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cmdc.201100089","article-title":"Structure-activity studies of RFamide peptides reveal subtype-selective activation of neuropeptide FF1 and FF2 receptors","volume":"6","author":"Findeisen","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbr.2012.05.015_bib0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.bbr.2012.05.015_bib0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-4328(02)00374-1","article-title":"Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice","volume":"141","author":"Redrobe","year":"2003","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0091-3057(02)00881-X","article-title":"Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety","volume":"73","author":"Mar","year":"2002","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2012.05.015_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2004.09.001","article-title":"Contrasting grooming phenotypes in C57Bl\/6 and 129S1\/SvImJ mice","volume":"1028","author":"Kalueff","year":"2005","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2004.11.010","article-title":"Contrasting grooming phenotypes in three mouse strains markedly different in anxiety and activity (129S1, BALB\/c and NMRI)","volume":"160","author":"Kalueff","year":"2005","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomised rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.bbr.2012.05.015_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/brbi.1996.0001","article-title":"The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression","volume":"10","author":"Song","year":"1996","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.bbr.2012.05.015_bib0215","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0220","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2012.05.015_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","article-title":"Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats","volume":"156","author":"Gregus","year":"2005","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0230","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1037\/0735-7044.118.6.1365","article-title":"Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats","volume":"118","author":"Kalynchuk","year":"2004","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.bbr.2012.05.015_bib0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The Neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(80)90012-6","article-title":"The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs","volume":"2","author":"File","year":"1980","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.bbr.2012.05.015_bib0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25 years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2009.02.033","article-title":"Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors","volume":"1266","author":"Goyal","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainresbull.2008.05.007","article-title":"Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression","volume":"77","author":"Vieyra-Reyes","year":"2008","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.bbr.2012.05.015_bib0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.npep.2012.01.002","article-title":"Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity","volume":"46","author":"Olesen","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbr.2012.05.015_bib0265","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00029-3","article-title":"Effects of olfactory bulbectomy on neuropeptide gene expression in the rat olfactory\/limbic system","volume":"86","author":"Holmes","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.05.015_bib0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0091-3057(00)00358-0","article-title":"Olfactory bulbectomy increases met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures","volume":"67","author":"Primeaux","year":"2000","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.bbr.2012.05.015_bib0275","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1523\/JNEUROSCI.18-15-05565.1998","article-title":"Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain","volume":"18","author":"Dumont","year":"1998","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.bbr.2012.05.015_bib0280","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.mp.4002095","article-title":"Stress-induced changes in primate prefrontal profiles of gene expression","volume":"12","author":"Karssen","year":"2007","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.bbr.2012.05.015_bib0285","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ajmg.b.30629","article-title":"Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants","volume":"147B","author":"Domschke","year":"2008","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.bbr.2012.05.015_bib0290","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.108.144634","article-title":"The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydrobenzothiepino[5,4-d]thiazol-2-yl)amino]cycloh exyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity","volume":"328","author":"Walker","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.bbr.2012.05.015_bib0295","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(01)00768-3","article-title":"Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat","volume":"414","author":"Kask","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0300","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijo.0801472","article-title":"Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade","volume":"25","author":"Della Zuana","year":"2001","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.bbr.2012.05.015_bib0305","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.peptides.2009.04.006","article-title":"Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice","volume":"30","author":"Moriya","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2012.05.015_bib0310","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0196-9781(00)00156-X","article-title":"[D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake","volume":"21","author":"Parker","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.bbr.2012.05.015_bib0315","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.3748\/wjg.14.6312","article-title":"Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass","volume":"14","author":"Higuchi","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.bbr.2012.05.015_bib0320","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm0698-718","article-title":"Role of the Y5 neuropeptide Y receptor in feeding and obesity","volume":"4","author":"Marsh","year":"1998","journal-title":"Nature Medicine"},{"key":"10.1016\/j.bbr.2012.05.015_bib0330","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2004.09.001","article-title":"Contrasting grooming phenotypes in C57Bl\/6 and 129S1\/SvImJ mice","volume":"1028","author":"Kalueff","year":"2004","journal-title":"Brain research"},{"key":"10.1016\/j.bbr.2012.05.015_bib0335","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812003361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812003361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T13:33:20Z","timestamp":1743168800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812003361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0166432812003361"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.05.015","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}